{
  "data": {
    "indicator": {
      "slug": "bispecific-antibody-approvals",
      "name": "Bispecific antibody approvals",
      "definition": "Total number of bispecific antibody therapies authorized for commercial marketing.",
      "unit": "count",
      "scale": "1",
      "default_unit": "count",
      "default_scale": "1"
    },
    "scale": "1",
    "unit": "count",
    "region": {
      "code": "CN",
      "name": "China",
      "type": "country"
    },
    "points": [
      {
        "period_start": "2025-01-01",
        "period_label": "2025",
        "value": 4,
        "scale": "1",
        "unit": "count",
        "value_type": "actual",
        "statistic_id": "stat_VTRXBDTB1NEFN7JEV4E02EV9S9",
        "url": "https://statorigin.org/stat/stat_VTRXBDTB1NEFN7JEV4E02EV9S9",
        "source_org": "DIA",
        "source": {
          "org": "DIA",
          "org_short_name": "DIA",
          "document_title": "2025 NMPA Approvals: China Clears Record Number of New Drugs",
          "document_url": "https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/",
          "locator": "Established Modalities Maintain a Larger Presence",
          "published_date": null
        }
      }
    ],
    "available_regions": [
      "CN"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}